Concepedia

Jason C. Legg

JC

Statistics

Publications

20

Citations

3.1K

H-Index

15

Active since

2001

Affiliations

Amgen (United States)(Current)

Duke University

University of Calgary

Policy Analysis (United States)

Brigham and Women's Hospital

Jason C. Legg is an author at Amgen (United States) specializing in medicine, public health, and thrombosis.

Top concepts

Publications per year

2001–2020

20

Publications

20

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Marc S. Sabatine, Robert P. Giugliano, Stephen D. Wiviott et al. · New England Journal of Medicine · 2015 · 1.5K citations · Full text

, , +19

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

John R. Teerlink, Rafael Díaz, G. Michael Felker et al. · New England Journal of Medicine · 2020 · 625 citations · Full text

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Jennifer G. Robinson, Bettina S. Nedergaard, William J. Rogers et al. · JAMA · 2014 · 492 citations

Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings

Derek Weycker, Richard Barron, Alex Kartashov et al. · Journal of Oncology Pharmacy Practice · 2013 · 88 citations

A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia

Brian Dulisse, Xiaoyan Li, Julie Gayle et al. · Journal of Medical Economics · 2013 · 83 citations

, , +22

1–5 of 20